RYTM:NASDAQ, Rhythm Pharmaceuticals, Inc.

RYTM stock overview

Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ) closed at $92.18 on October 27, 2026, up 3.03% on the day. The stock trades 24.6% below its 52-week high of $122.20 and 23.7% above its 52-week low of $74.50. Over the past year, it lost 19.8%. Rhythm Pharmaceuticals, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$92.18
Day change
+3.03%
Volume
398,019
Average volume
667,235
Market cap
6B+
52-week range
$74.50 – $122.20
50-day average
$98.89
200-day average
$97.38

Price action over the past year

In 252 trading sessions since October 27, 2025, RYTM closed higher on 126 days (50%). Its best day was March 31, 2026 (+12.58%) and its worst was November 4, 2025 (-7.69%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

RYTM news

About Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.

Similar stocks

Find more stocks like RYTM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.